In this study, 483 (93.10%) were at WHO clinical stage I, 123 (23.70%) were diagnosed with opportunistic infection within the last six months, and majority, 282 (54.30%), had moderate CD4 category with a CD4 count of 200-499 cells/mm3. The gene discussed is CD4; the disease is Opportunistic infection.